ð äžçã¬ã€ãã©ã€ã³èšåºãã£ã«ã¿ãŒ ïœã©ãããèªãããè¿·ããªãããã®å°å³
ãã®ã·ãªãŒãºã¯ã
çŸæ£å¥ã®ç¥èéã§ã¯ãããŸããã
ããã§ç©ã¿äžããŠããã®ã¯ã
äžçåºæºã§èããããã®ã倿ã®å°å³ãã§ãã
ååã®èšäºã§ç€ºããéãã
æ¬ã·ãªãŒãºã¯
ç¥èã®éãå¢ããããã®ãã®ã§ã¯ãªãã
å°éè·ãšããŠã®å€ææ§é ãè²ãŠãèšèšã«ãªã£ãŠããŸãã
ãã®ã¬ã€ãã¯ã
ããªãã®ç«å Žã»é¢å¿ã»å°éé åã«å¿ããŠã
ã©ã®é çªã§èªããšãæèã®ã¬ã€ã€ãŒãäžæ®µãã€äžããã
ã瀺ãããã®å°å³ã§ãã
ãã®ã·ãªãŒãºã®å šäœæ§é
å
š28æ¬ã¯ã
8ã€ã®ãã§ãŒãºã«åãããŠããŸãã
çªå·ã¯æçš¿é ã§ãããšåæã«ã
倿ã
æè¡ïŒäœããããïŒ
â æ§é ïŒã©ãèãããïŒ
â èŠéïŒã©ããŸã§èŠããïŒ
ãžãšåºããé çª
ã§ããããŸãã
ãã§ãŒãº1ïœå®å šèšèšããå§ãã
ç®çïŒéå°å»çã»å®³ã»ãªã¹ã¯ããèããè¶³å Žãã€ãã
1. LBPïœACPïŒç±³åœå
ç§åŠäŒïŒ
å¯é¡ïŒè
°çæ²»çã®âãããããªãå»çâèšèšå³
2. OAïœOARSIïŒ2019ïŒ
å¯é¡ïŒäœµåçãããã¡ã€ã«å¥ã»ãªã¹ã¯ç®¡çã¢ã«ãŽãªãºã
3. å¿äžå
šïœESC
å¯é¡ïŒéç床ã»äºåŸã»åå
¥é¢ãé²ãå»çèšèš
4. COPDïœGOLD
å¯é¡ïŒçç¶åé¡ãšå¢æªäºé²ã®äžçæšæºãã¬ãŒã
ð ãäœãããããããå ã«ããäœãé¿ãããããåŠã¶ãã§ãŒãº
ãã§ãŒãº2ïœç掻ãšããŠæ¯ãã
ç®çïŒçŸæ£ãçæŽ»æ©èœã»äººçèšèšãšããŠèªã
5. LBPïœNICEïŒNG59ïŒ
å¯é¡ïŒè
°çãâçæŽ»æ©èœé害âãšããŠèšèšãã
6. PDïœNICEïŒNG71ïŒ
å¯é¡ïŒããŒãã³ãœã³ç
ãâ人çèšèšã®çŸæ£âãšããŠæ¯ãã
7. èªç¥çïœNICE
å¯é¡ïŒèšºæåŸã®âçæŽ»ãšæææ±ºå®ã®èšèšå³â
8. è³åäžïœNICE
å¯é¡ïŒå埩æãã瀟äŒåå ãŸã§ã®é£ç¶æ¯æŽ
ð å»çããæ²»ãããããæ¯ããããžåºãããã§ãŒãº
ãã§ãŒãº3ïœçŸå Žã§ã©ãå®è£ ããã
ç®çïŒä»å ¥ãèšèšã§ãã人ã«ãªã
9. LBPïœAPTA / JOSPT CPG
å¯é¡ïŒè
°çãªãã®å®è£
ãããã³ã«
10. PDïœAPTA CPG
å¯é¡ïŒæ©è¡ã»Cueingã»åŒ·åºŠèšèšã®äžçæšæº
11. è³åäžïœAPTA CPG
å¯é¡ïŒå埩éã»åŒ·åºŠã»å埩èšèš
12. å¿äžå
šïœAHA / ACC
å¯é¡ïŒå¿äžå
šãšããå»çã·ã¹ãã ã®èšèš
13. å¿äžå
šïœAPTA CPG
å¯é¡ïŒPTãè¡ãè©äŸ¡ã»éååŠæ¹ã»åå
¥é¢äºé²ãããã³ã«
14. COPDïœATS
å¯é¡ïŒåŒåžãªãã®âç¶ç¶ã§ããèšèšâ
15. è¡OAïœAPTA CPG
å¯é¡ïŒè¡OAãªãã®è©äŸ¡ã»ä»å
¥ãããã³ã«
ð 倿ãå ·äœçãªä»å ¥èšèšãžèœãšããã§ãŒãº
ãã§ãŒãº4ïœéžæã®æ§é ãåŠã¶
ç®çïŒèª¬æã§ããå°éè·ã«ãªã
16. OAïœACR / Arthritis FoundationïŒ2019ïŒ
å¯é¡ïŒåŒ·ãæšå¥šãšSDMã§èªãâéžæã®æ§é â
17. ç³å°¿ç
ïœADA
å¯é¡ïŒè¡ç³ã§ã¯ãªãâçæŽ»ç®¡ççŸæ£âãšããŠèªã
ð ãæ£ããããããçŽåŸã§ãããå»çãž
ãã§ãŒãº5ïœãšããã³ã¹ã®äœçœ®ã¥ã
ç®çïŒåãã£ãŠããããšïŒåãããªãããšãæŽçãã
18. PDïœMDSïŒEBMã¬ãã¥ãŒïŒ
å¯é¡ïŒå¹ãã»åãããªãã»åŠå®ãããŠããä»å
¥ã®å°å³
19. èªç¥çïœCochrane
å¯é¡ïŒéè¬ç©ä»å
¥ã®ãšããã³ã¹æ§é
20. å¿ãªãïœCochrane / EAPC
å¯é¡ïŒå¿ãªãã®å¹æãšéç
ð ãšããã³ã¹ãå€æã®ææãšããŠäœ¿ããã§ãŒãº
ãã§ãŒãº6ïœå€è·çš®ã®å€æè»žãèªã
ç®çïŒé£æºãšèª¬æåãåŒãäžãã
21. è³åäžïœAHA / ASA
å¯é¡ïŒè¶
æ¥æ§æãäºæ¬¡äºé²ã®å»ç倿å°å³
22. LBPïŒç¥çµçç¶ïŒïœNASS
å¯é¡ïŒå骚ç¥çµçã»ç»åã»æè¡ã®å€æåºæº
23. å¿çŸæ£ïœESCïŒãã©ããŒã¢ããç·šïŒ
å¯é¡ïŒæ
¢æ§å¿äžå
šã®é·æç®¡çèšèš
ð ä»è·çš®ãäœãåºæºã«æ±ºããŠããããçè§£ãããã§ãŒãº
ãã§ãŒãº7ïœäººçå建ãšäºé²
ç®çïŒãªãã人çã®åèšèšãšããŠæãã
24. 倧è
¿éªšè¿äœéšéªšæïœNICE
å¯é¡ïŒæ©ææè¡ãšåšå®
埩垰ã¢ãã«
25. 倧è
¿éªšè¿äœéšéªšæïœCochrane
å¯é¡ïŒå€è·çš®ãªãã®å¹æ
26. MCIïœWHO
å¯é¡ïŒèªç¥æ©èœäœäžã®äºé²èšèš
ð å埩åŸã®äººçãŸã§èŠéãåºãããã§ãŒãº
ãã§ãŒãº8ïœç€ŸäŒèšèšãž
ç®çïŒãªããæš©å©ãšã·ã¹ãã ãšããŠèãã
27. å°åãªãïœWHOïŒRehabilitation 2030 / CBRïŒ
å¯é¡ïŒãªãããªã瀟äŒã®è²¬ä»»ãšããŠèšèšãã
28. æ
¢æ§çŒçïœIASP / WHO
å¯é¡ïŒçã¿ãã·ã¹ãã ãšããŠèªã
ð å°éè·ã®èŠéãå人ãã瀟äŒãžåºãããã§ãŒãº
çŸæ£ã»é¢å¿å¥ïœããããã«ãŒãäžäŸ
ðŠŽ è °çãå°éã«ããŠããæ¹
1 â 5 â 9 â 22 â 28
å®å
šèšèš â çæŽ»èšèš â å®è£
â ç¥çµå€æ â æ
¢æ§çŒç
ðŠµ OAã»éååšé å
2 â 15 â 16 â 18 â 27
å®å
šèšèš â å®è£
â éžææ§é â ãšããã³ã¹å°å³ â 瀟äŒèšèš
ð§ ç¥çµç³»ïŒPDã»è³åäžã»èªç¥çïŒ
6 â 10 â 18 â 21 â 27
人çèšèš â å®è£
â ãšããã³ã¹å°å³ â å»åž«å€æè»ž â 瀟äŒèšèš
â€ïž å éšçŸæ£ã»æ ¢æ§çŸæ£ç®¡ç
3 â 12 â 13 â 20 â 23 â 26
äºåŸèšèš â å»çã·ã¹ãã â PTå®è£
â 广ãšéç â é·æç®¡ç â äºé²èšèš
â»æ¬ã·ãªãŒãºã¯çŸæ£å¥ãŸãšãã§ã¯ãããŸããã
çŸæ£ãéããŠâ倿æ§é âãåŠã¶èšèšã§ãã
ç«å Žå¥ïœããããã«ãŒãäžäŸ
ð± è¥æã»ã©ãã¹ã
1 â 5 â 9 â 16
å®å
šèšèš â çæŽ»èšèš â å®è£
â 説æå
ð§âð« æå°è ã»æè²æ åœ
1 â 9 â 18 â 27
å®å
šèšèš â å®è£
â ãšããã³ã¹å°å³ â 瀟äŒèšèš
ð§âðŒ 管çè·ã»éå¶åŽ
3 â 12 â 23 â 27
äºåŸèšèš â å®è£
èšèš â é·æç®¡ç â å°åèšèš
ãã³ããªã³ã°ã®æå³
ãã®çªå·ã¯ã æçš¿é ã§ãããšåæã«âæèã®æé·é âã§ãã
äžããèªãã»ã©ã
æè¡ â 倿 â èšèš â 瀟äŒçèŠéãžãšã
å°éè·ãšããŠã®èŠéãåºããèšèšã«ãªã£ãŠããŸãã
ç¹éã·ãªãŒãºïœè»¢åïŒäºé²ïŒ
æ¬ã·ãªãŒãºã®æ¬ç·šïŒ1ïœ28ïŒã¯ã
çŸæ£ãããŒããéããŠå€ææ§é ãåŠã¶ããŒããããã§ãã
äžæ¹ã§ã
転åäºé²ã¯ç¹å®ã®çŸæ£ã§ã¯ãªãã
èº«äœæ©èœ
èªç¥æ©èœ
è¬å€
ç°å¢
çæŽ»æ©èœ
å°åè³æº
ãããã
亀差ããæšªæããŒãã§ãã
ãã®ããã
æ¬ç·šãšã¯å¥ã«ã転åïŒäºé²ïŒãã·ãªãŒãºãèšããŠããŸãã
ðäžçã¬ã€ãã©ã€ã³èšåºãã£ã«ã¿ãŒïœè»¢åïŒäºé²ïŒ
â World Falls GuidelinesïŒWFGïŒ
å¯é¡ïŒè»¢åãâäºæž¬ã»äºé²ã»åå¥åã»åå åâã§èšèšãã
ð 転åäºé²ã®äžçæšæºãã¬ãŒã ãåŠã¶
â¡ NICE NG249
å¯é¡ïŒè»¢åäºé²ãâå°åã·ã¹ãã ãšããŠå®è£
ããâããã®èšèšå³
ð è©äŸ¡ã»ããŒã ã»å°åè³æºãã©ãã€ãªãããåŠã¶
⢠Cochrane / USPSTF
å¯é¡ïŒè»¢åäºé²ã®âå¹ãé åãšéçâãæŽçãã
ð äœãã©ããããå¹ãã®ããã©ãã§ç·ãåŒãã®ããåŠã¶
ãã®3æ¬ã¯ã
â èãæ¹ïŒWFGïŒ
â
â¡å®è£ æ¹æ³ïŒNICEïŒ
â
â¢ãšããã³ã¹ã®äœçœ®ã¥ãïŒCochrane / USPSTFïŒ
ãšããæ§é ã«ãªã£ãŠããŸãã
転åäºé²ã«é¢ããæ¹ã¯ã
æ¬ç·šãšã¯ç¬ç«ããŠâ ââ¡ââ¢ã®é ã§èªãã§ããã ãããšå¹žãã§ãã
æåŸã«
ç¹°ãè¿ãã«ãªããŸããã
ãã®ã·ãªãŒãºã¯ãçŸæ£å¥ã®ç¥èéã§ã¯ãããŸããã
äžçåºæºã§èããããã®å€æã®å°å³ãè²ãŠãããŒãããã
ã§ãã
ã©ãããèªããã«ã
ç¹å¥ãªæ£è§£ã¯ãããŸããã
èªã¿é²ãããã¡ã«ã
çŸæ£ã®ç¥èã§ã¯ãªããå€æã®æ§é ãå°ããã€ç©ã¿éãªãã¯ãã§ãð
ä»åŸã¯ãŸãã
ã¬ã€ãã©ã€ã³ãèªãããã®åææ¡ä»¶ïŒè³ªã»æšå¥šã»é©çšã»ã¢ãŠãã«ã ïŒãæŽçããŸãã
ãã®ããã§ã å®éã®äžçã¬ã€ãã©ã€ã³ãã
èšåºãã£ã«ã¿ãŒãéããŠèªã¿è§£ããŠãããŸãã
çããã®èšåºã®äžå©ã«ãªãã°å¹žãã§ãðââïž
ãããªãšæã£ããå¿æŽãããïŒ
ãããŸã§èªãã§ããã ãããããšãããããŸãã
ãããããããã°å¿æŽïŒãµããŒãïŒããã ãããšå¬ããã§ãã
ããã ãããµããŒãã¯ãnoteæŽæ°ãè³æäœæãªã©ã®æŽ»åè²»ãšããŠå€§åã«äœ¿ãããŠããã ããŸãã